Role of flavonoids in age-related macular degeneration

Biomed Pharmacother. 2023 Mar:159:114259. doi: 10.1016/j.biopha.2023.114259. Epub 2023 Jan 16.

Abstract

A common eye disorder known as age-related macular degeneration (AMD) eventually results in blindness and vision loss. AMD has a complicated and poorly understood aetiology. The main pathological processes associated with AMD include oxidative damage, inflammation, and neovascularization. Flavonoids are naturally occurring bioactive substances with extensive distribution and antioxidant, anti-inflammatory, and neovascularization inhibitory properties. Several in vitro and in vivo AMD-related models pertinent to vision and this ocular ailment have been used to assess the mechanisms of action of various flavonoids. This article will discuss the research progress of flavonoids in AMD, especially the characteristics and mechanism of flavonoids in treating AMD.

Keywords: Age-related macular degeneration; Anti-angiogenic; Anti-inflammatory; Antioxidant; Flavonoid.

Publication types

  • Review

MeSH terms

  • Eye
  • Flavonoids* / pharmacology
  • Flavonoids* / therapeutic use
  • Humans
  • Inflammation / complications
  • Macular Degeneration* / drug therapy
  • Neovascularization, Pathologic

Substances

  • Flavonoids